Plexus Stock Tumbles 7%, Wiping Out $367 Million In Market Value
Shares were on pace for their second decline of 5% or more this month, despite quarterly results above the company's forecasts.
Plexus, which designs and manufactures complex products for other companies, tumbled 6.6% to $194.95 in Friday trading, as of 11:26 AM ET, wiping out $367 million in market value. The stock was on pace for its second decline of 5% or more this month.
A Retreat From The High
Plexus had a market value of $5.2 billion in Friday trading. At Thursday's close, shares were up 42% for the year, compared with a 5% gain for the S&P 500.
The recent stretch has been weaker: shares had fallen 11% over the previous month and were 31% below their highest close of the past year.
A Smaller Board Ahead
Friday's decline followed Thursday's announcement that chair Foate would leave the board after the annual meeting, according to Plexus's SEC filing. Plexus said the departure was a personal decision and did not stem from disagreements over company operations.
Current director Michael V. Schrock was selected to become chair, provided shareholders reelect him. Foate's departure will reduce the board to nine directors from ten.
Results Beat Plexus's Own Forecasts
Plexus reported fourth-quarter revenue of $1.4 billion in its October 28 earnings release, exceeding guidance of $1.33 billion to $1.38 billion. Earnings of $2.51 per diluted share topped its $2.18 to $2.34 forecast, and operating margin reached 6.0%, above the projected 5.5% to 5.9%.
Adjusted earnings were $2.84 per share, excluding $0.33 in stock-based pay expense. Adjusted operating margin was 6.7%.
Todd Kelsey, Plexus's president and chief executive officer, said the team "effectively captured stronger end-market demand and continued to support new program ramps."
Plexus serves customers in medical devices, aerospace and defense, industrial automation and semiconductor equipment. It works on customers' products from design and supply-chain management through assembly, repair and refurbishment, rather than selling proprietary products of its own.
The company won 36 manufacturing programs during the quarter, representing $290 million in annual revenue once fully in production. It generated $6.4 million in free cash flow and bought back $21.4 million of shares at an average price of $254.32 per share.
Plexus expects first-quarter revenue of $1.41 billion to $1.46 billion and earnings of $2.16 to $2.32 per diluted share. Its adjusted earnings forecast is $2.46 to $2.62, excluding $0.30 in stock-based pay expense.
Plexus entered fiscal 2027 with its entire $100 million share-repurchase authorization available, following completion of its 2026 program.
Sources
- Signs of slowdown in US interest rate hike lift Bursa's Tech Index — The Edge Malaysia
- Plexus Law : Articles :: Law360 — law360.com
- The company's filing (Plexus) — SEC filing
- Plexus — Form 10-K for the fiscal year ended 2026-10-03 (quarterly results) — SEC EDGAR
- Plexus — earnings release (Form 8-K, Item 2.02), filed 2026-10-28 — SEC EDGAR